Comment: Biomarkers for mild traumatic brain injury

While the majority of mild traumatic brain injuries (mTBIs) are single and uncomplicated and complete recovery is expected, a subset of individuals experience persistent postconcussive symptoms (PCS) and substantial disability. There is a need for accurate and reliable biomarkers that are tied to the pathophysiologic mechanisms of mTBI, and that track and predict neuropsychiatric outcomes.1